DelMar Pharmaceuticals (DMPI) Reaches $2.12 After 4.00% Up Move; 1 Bullish Analysts Covering Green Dragon Gas Ltd. (LON:GDG)

July 11, 2017 - By Darrin Black

Among 3 analysts covering Green Dragon Gas Ltd (LON:GDG), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Green Dragon Gas Ltd had 15 analyst reports since July 23, 2015 according to SRatingsIntel. Citigroup maintained Green Dragon Gas Ltd. (LON:GDG) on Wednesday, March 16 with “Neutral” rating. The stock of Green Dragon Gas Ltd. (LON:GDG) has “Buy” rating given on Monday, August 17 by Cantor Fitzgerald. The rating was maintained by Peel Hunt on Monday, January 9 with “Hold”. Cantor Fitzgerald maintained Green Dragon Gas Ltd. (LON:GDG) rating on Monday, November 30. Cantor Fitzgerald has “Buy” rating and GBX 806 target. On Monday, January 4 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The firm has “Buy” rating given on Tuesday, October 4 by Peel Hunt. The stock of Green Dragon Gas Ltd. (LON:GDG) earned “Buy” rating by Peel Hunt on Monday, April 4. The firm earned “Hold” rating on Thursday, October 13 by Peel Hunt. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, February 3. Peel Hunt maintained Green Dragon Gas Ltd. (LON:GDG) on Monday, June 5 with “Hold” rating. See Green Dragon Gas Ltd. (LON:GDG) latest ratings:

05/06/2017 Broker: Peel Hunt Rating: Hold Maintain

The stock of DelMar Pharmaceuticals Inc (NASDAQ:DMPI) is a huge mover today! About 67,897 shares traded. DelMar Pharmaceuticals Inc (NASDAQ:DMPI) has declined 57.32% since July 11, 2016 and is downtrending. It has underperformed by 74.02% the S&P500.The move comes after 5 months positive chart setup for the $28.19 million company. It was reported on Jul, 11 by Barchart.com. We have $2.20 PT which if reached, will make NASDAQ:DMPI worth $1.13 million more.

Green Dragon Gas Ltd. is a Hong Kong investment holding company. The company has market cap of 103.51 million GBP. The Company, through its subsidiaries, is engaged in the exploration, development and production of coal bed methane in the People’s Republic of China . It currently has negative earnings. The coal bed methane activities in the PRC are conducted through production sharing arrangements with China United Coal Bed Methane Corporation Ltd. and PetroChina Company Limited.

The stock decreased 4.91% or GBX 3.25 on July 11, reaching GBX 63. About shares traded. Green Dragon Gas Ltd. (LON:GDG) has 0.00% since July 11, 2016 and is . It has underperformed by 16.70% the S&P500.

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The company has market cap of $28.19 million. The Firm focuses on the treatment of cancer. It currently has negative earnings. The Firm is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme , a form of brain cancer.